Combination

Details for Australian Patent Application No. 2009100698 (hide)

Owner AstraZeneca AB

Inventors Thalberg, Kyrre; Trofast, Jan

Agent Freehills

Pub. Number AU-B-2009100698

Filing date 17 July 2009

Opi date 15 April 2010

International Classifications

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61M 15/00 (2006.01) Inhaling devices

Event Publications

30 July 2009 Innovation Patent Application Filed

27 August 2009 Innovation Patent Open to Public Inspection

  Published as AU-B-2009100698

27 August 2009 Innovation Patent Sealed

15 April 2010 Certified Innovation Patents

  Published as AU-B-2009100698

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009100699-A data communication method

2009100697-A system and process for facilitating electronic financial transactions